Preliminary clinical trial of a new spasmolytic (AD-205) in gastrointestinal disorders.
SLANGER
A
A
D002317:Cardiovascular Agents; D005762:Gastroenterology / Q000628:therapy*; D005767:Gastrointestinal Diseases; D009125:Muscle Relaxants, Central / Q000628:therapy*; D010276:Parasympatholytics
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics
GASTROENTEROLOGY/therapy; MUSCLE RELAXANTS/therapy